Prevalence and prognosis of unclassifiable interstitial lung disease

European Respiratory Journal

Volumn 43, Issue 5, 2014, Pages 1529-1530

  Troy, Lauren ^a   Glaspole, Ian ^b   Goh, Nicole ^c   Zappala, Chris ^d   Hopkins, Peter ^e   Wilsher, Margaret ^f   Moodley, Yuben ^g   Corte, Tamera ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b Dept of Allergy Immunology and Respiratory Medicine Alfred Health ^*  (Australia)

^c AUSTIN HEALTH   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^e THE PRINCE CHARLES HOSPITAL   (Australia)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE CONTROL; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; LETTER; LUNG BIOPSY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SEROLOGY; UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE; FEMALE; LUNG; LUNG DISEASES, INTERSTITIAL; MALE; PATHOPHYSIOLOGY;

FEMALE; HUMANS; LUNG; LUNG DISEASES, INTERSTITIAL; MALE;

EID: 84899893906     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00003414     Document Type: Letter

References (7)

1. Ryerson CJ, Urbania TH, Richeldi L, et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J 2013; 42: 750-757.
2. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-748.
3. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: 531-537.
4. Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med 2004; 170: 904-910.
5. Cottin V. Significance of connective tissue disease features in pulmonary fibrosis. Eur Respir Rev 2013; 221: 273-280.
6. Raghu G, Anstrom KJ, King TE Jr, et al. Prednisone, azathioprine and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012; 366: 1968-1977.
7. Cottin V, Wells A. Unclassified or unclassifiable interstitial lung disease: confusing or helpful disease category? Eur Respir J 2013; 42: 576-579.